NASDAQ · Healthcare · Statistics
Amgen Inc. (AMGN) Valuation & Key Statistics
Valuation, profitability, balance-sheet health, and risk metrics for AMGN, refreshed each market session.
Section freshness
Prices as of Sep 8, 2:13 PM EDT · Fundamentals checked Sep 8, 2:02 PM EDT · Statements Jun 30, 2026
Key metrics at a glance
The numbers most investors check first
Market cap
$214.99B
P/E (TTM)
24.72
Forward P/E
—
FCF yield
4.73%
Return on equity
74.80%
Dividend yield
2.31%
Valuation
- Market cap
- $214.99B
- Enterprise value
- $252.86B
- P/E (TTM)
- 24.72
- Price / sales
- 5.64
- Price / book
- 18.39
- EPS (TTM)
- $16.09
Long-run compounding
20-year CAGR and aggregate price growth.
Adjusted daily closes are annualized over the tracked 20-year window; dividends are not included in this price-only return view.
- 20Y CAGR
- 12.01%
- From earliest tracked adjusted close on September 8, 2006
- Aggregate CAGR
- 28.73%
- 1Y, 3Y, 5Y, 10Y blended CAGR
- First tracked close
- $45.34
- September 8, 2006
- History span
- 20 yrs
- Sep 8, 2006 to Sep 4, 2026 · 5,029 closes
- Latest tracked close
- $437.23
- September 4, 2026
- 20Y high
- $447.03
- August 25, 2026
- 20Y low
- $39.16
- March 20, 2008
- History source
- Long range
- Yahoo Finance
Valuation map
Risk and scale
Less volatile than the market
Pro formula stack
Ratios investors search for after the headline quote.
These are TECHi-computed from overview, income statement, balance sheet, and cash-flow rows when market-data sources expose the ingredients.
- EV / revenue
- 6.64
- Enterprise value / TTM revenue
- FCF yield
- 4.73%
- TTM free cash flow / market cap
- FCF / share
- $18.82
- TTM free cash flow / shares outstanding
- Earnings yield
- 4.05%
- Inverse P/E
- Rule of 40
- 36.24%
- Revenue growth + FCF margin
- ROIC approx.
- 23.06%
- NOPAT / invested capital
- CROIC
- 20.53%
- FCF / invested capital
- TECHi quality score
- 5 / 7
- 7-point profitability, cash, leverage, and trend check
Quality and capital returns
TTM free cash flow / TTM revenue
TTM FCF / TTM net income
TTM revenue / market cap
Balance-sheet and reinvestment reads
Total debt / TTM FCF
Capital intensity of the business
Distress and optionality read
AMGN Altman Z-score needs a fuller balance sheet.
TECHi computes a non-financial-company Altman-style score from working capital, retained earnings, EBIT, market value, liabilities, revenue, and assets. It is not a bankruptcy prediction, but it gives pro readers a fast stress screen that most quote pages do not show beside live valuation metrics.
- Net cash / share
- $-70.05
- Cash minus debt, per share
- Working capital
- $9.46B
- Current assets minus current liabilities
- Debt growth YoY
- -3.54%
- Latest quarter vs same quarter last year
Valuation read
AMGN trades at 24.72× trailing earnings.
A trailing P/E in line with the broad market means AMGN is being priced like an average earner.
Profitability
- Gross margin
- 47.46%
- Operating margin
- 29.99%
- Net margin
- 22.95%
- Return on equity
- 74.80%
- Return on assets
- 9.14%
- Debt / equity
- 4.44
- Current ratio
- 1.37
- >1 = covers near-term liabilities
- Beta (5Y)
- 0.43
Margin profile
Profitability read
AMGN converts 23.0% of revenue into net income.
Net margins above 20% are the hallmark of pricing-power businesses — software, brands, and franchises. Watch for trend, not just level: a falling margin in this band still erodes the multiple.
Per-share & range
- Dividend yield
- 2.31%
- Forward yield
- Payout ratio
- 15.66%
- Dividend per share / EPS — lower leaves more room to grow
- Dividend coverage
- 7.47×
- TTM free cash flow / dividends paid — above 1× is self-funded
- Shares outstanding
- 540.63M
- 52w high
- $447.03
- 52w low
- $269.77
Corporate actions
Stock split history
Adjusted for all historical splits
- Split events
- 0
Reported fundamentals
Company statistics fields
These figures come from the latest issuer filings and live quote-derived formulas.
- Revenue (TTM)
- $38.09B
- TECHi unified data
- Book value
- $21.62
- TECHi unified data
- Revenue / share
- $70.46
- TECHi unified data
- Earnings growth YoY
- 64.91%
- TECHi unified data
- Revenue growth YoY
- 9.53%
- TECHi unified data
- 50-day average
- $395.32
- TECHi unified data
- 200-day average
- $354.22
- TECHi unified data
- Dividend / share
- $2.52
- Yahoo Finance
- Ex-dividend date
- August 21, 2026
- Yahoo Finance
Frequently asked
Common questions.
What is Amgen Inc.'s market capitalization?
Amgen Inc. (AMGN) has a market capitalization of $215.0 billion.
What is AMGN's P/E ratio?
AMGN trades at a trailing price-to-earnings ratio of 24.72.
Where do TECHi's AMGN statistics come from?
AMGN statistics combine exchange quotes with company filings through TECHi's market-data providers. Any figure that is missing or out of date is left blank rather than estimated.